Moreover, these studies demonstrated that the antibody exhibited over 20-fold greater affinity for FcγRIIIa banding than its fucosylated counterpart and mediates concentration-dependent suppression of FGFR2 phosphorylation and cell proliferation in SNU-16 gastric cancer cells [16]. The gene discussed is FGFR2; the disease is gastric cancer.